Glenmark Pharmaceuticals Ltd.
Snapshot View

368.00 -16.70 ▼-4.3%

26 September 2022, 04:12:41 PM
Volume: 770,598

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.glenmarkpharma.com
Market Cap 10,382.38 Cr.
Enterprise Value(EV) 12,642.62 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 29.33 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 12.54 Trailing Twelve Months Ending 2022-06
Industry PE 30.55 Trailing Twelve Months Ending 2022-06
Book Value / Share 328.93 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.12 Calculated using Price: 367.95
Dividend Yield 0.68 Period Ending 2022-03
No. of Shares Subscribed 28.22 Cr. 282,168,156 Shares
FaceValue 1
Company Profile
The Company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Specialty Business: Drug Discovery: Glenmark's ground-breaking drug discovery effort is primarily focused in the areas of inflammation [asthma/COPD, rheumatoid arthritis etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain]. Specialty Business: Formulations Business: Glenmark's formulations business is currently organized many regions - India, Latin America, Central Eastern Europe and Semi Regulated Markets of Africa/Asia/CIS. The formulations business focuses on therapeutic areas viz. dermatology, anti-infective, respiratory, cardiac, diabetes, gynecology, CNS, and oncology.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-4.34%
1 Week
-0.62%
1 Month
-2.56%
3 Month
-4.20%
6 Month
-19.57%
1 Year
-27.57%
2 Year
-23.74%
5 Year
-39.91%
10 Year
-12.37%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 18.99 8.79 27.46 27.31 16.67 17.21 13.32 14.81 12.33
Return on Capital Employed (%) 15.04 12.40 18.53 20.54 14.77 16.47 14.04 15.30 14.19
Return on Assets (%) 7.51 2.58 8.52 11.33 7.40 7.98 6.17 7.11 6.74

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 2,763 2,983 1,783 3,630 4,493 5,163 5,605 6,071 7,065 9,087
Non Curr. Liab. 1,625 1,967 2,749 1,499 3,258 2,824 2,280 3,033 2,804 1,270
Curr. Liab. 2,201 2,949 3,777 3,999 2,703 3,288 4,021 4,126 4,201 4,689
Minority Int. 24 13 0 0 0 0 0 0 0 351
Equity & Liab. 6,614 7,912 8,309 9,128 10,453 11,275 11,906 13,229 14,069 15,397
Non Curr. Assets 2,887 3,150 2,978 3,224 3,578 4,286 5,209 6,425 6,709 7,115
Curr. Assets 3,727 4,763 5,331 5,904 6,875 6,989 6,697 6,804 7,360 8,282
Misc. Exp. not W/O
Total Assets 6,614 7,912 8,309 9,128 10,453 11,275 11,906 13,229 14,069 15,397

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 5,945 6,681 7,562 9,079 9,074 9,865 10,641 10,944 12,305 12,117
Other Income 11 7 20 37 91 208 160 50 167 291
Total Income 5,956 6,688 7,582 9,117 9,166 10,074 10,801 10,994 12,472 12,408
Total Expenditure -4,854 -5,467 -6,125 -7,043 -7,459 -8,280 -8,943 -8,860 -9,985 -9,939
PBIDT 1,102 1,221 1,457 2,074 1,707 1,794 1,858 2,135 2,487 2,470
Interest -189 -190 -179 -237 -286 -335 -377 -353 -298 -282
Depreciation -217 -300 -234 -264 -302 -326 -417 -444 -487 -520
Taxation -151 -334 -301 -383 -315 -376 -320 -412 -448 -507
Exceptional Items -187 -81 167 33 45 -261 -261
PAT 546 209 743 1,109 804 925 776 970 994 898
Minority Interest -3 0 0 0 0 0 0 -52 -71
Share Associate
Other Related Items
Consolidated Net Profit 542 210 743 1,109 804 925 776 970 942 828
Adjusted EPS 20 8 26 39 28 33 28 34 33 29

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 648 854 482 345 657 1,648 1,324 1,392 1,131 1,109
Cash Fr. Inv. -464 -368 -540 -880 -712 -1,013 -699 -784 -675 -333
Cash Fr. Finan. 195 -98 199 699 543 -469 -739 -445 -442 -520
Net Change 379 388 141 163 488 166 -114 164 14 255
Cash & Cash Eqvt 605 795 764 857 1,056 1,233 936 1,110 1,138 1,411

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 46.62 46.63 46.63 46.63 46.63 46.65 46.65 46.65 46.65
Public 53.38 53.37 53.37 53.37 53.37 53.35 53.35 53.35 53.35
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 23 Sep 2022
General updates
Glenmark Pharmaceuticals Limited has informed the Exchange about Company's Aurangabad Facility receives Establishment Inspection Report
Fri, 23 Sep 2022
General updates
Glenmark Pharmaceuticals Limited has informed the Exchange about Company's Aurangabad Facility receives Establishment Inspection Report
Fri, 23 Sep 2022
Press Release
Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 23-Sep-2022 titled Bausch Health and Glenmark Announce the approval of RYALTRIS?? in Canada

Technical Scans View Details >>

Mon, 26 Sep 2022
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Crossing 50 SMA From Above Close Crossing 50 SMA From Above

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 216,444.01 900.70 -2.2%
Divi's Laboratories Ltd. 97,676.51 3,670.00 +0.8%
Cipla Ltd. 85,998.13 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. 68,714.69 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. 61,530.49 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. 51,200.03 1,512.80 -0.2%
Max Healthcare Institute Ltd. 40,653.72 419.25 -1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 55.65 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-06 31.45 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-06 34.59 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.00 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.65 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.10 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-06 64.55 419.25 -1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.32 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-06 7.86 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-06 4.00 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.40 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.35 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.03 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.33 419.25 -1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-03 0.04 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 419.25 -1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 419.25 -1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 419.25 -1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 419.25 -1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 419.25 -1.8%

FAQ's On Glenmark Pharmaceuticals Ltd.

What is Glenmark Pharma share price?

Can I buy Glenmark Pharma shares now?

What is the Dividend Yield of Glenmark Pharma?

What is the Market Cap of Glenmark Pharma?

What are the key metrics to analyse Glenmark Pharma?

What is the 52 Week High and Low of Glenmark Pharma?

What is the trend of Glenmark Pharma share price?